{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:03:24Z","timestamp":1792411404929,"version":"4.4.0"},"reference-count":54,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405731\/2023-0"],"award-info":[{"award-number":["405731\/2023-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301522\/2025-1"],"award-info":[{"award-number":["301522\/2025-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"award":["405731\/2023-0"],"award-info":[{"award-number":["405731\/2023-0"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"award":["301522\/2025-1"],"award-info":[{"award-number":["301522\/2025-1"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-03205-24"],"award-info":[{"award-number":["APQ-03205-24"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-04839-24"],"award-info":[{"award-number":["APQ-04839-24"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"award":["APQ-03205-24"],"award-info":[{"award-number":["APQ-03205-24"]}],"id":[{"id":"https:\/\/ror.org\/00nc55f03","id-type":"ROR","asserted-by":"publisher"}]},{"award":["APQ-04839-24"],"award-info":[{"award-number":["APQ-04839-24"]}],"id":[{"id":"https:\/\/ror.org\/00nc55f03","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>In the SARS-CoV-2 endemic phase, assessing the effectiveness of COVID-19 booster doses in children is essential for public health policy. This study evaluated the vaccine effectiveness (VE) of three doses (primary series plus booster) against severe outcomes, comparing the pandemic and endemic periods and children with and without comorbidities. We carried out a cohort study based on the population, utilizing comprehensive Brazilian data from individuals under 18 years of age with confirmed SARS-CoV-2 infection, spanning from February 2020 to June 2025. The primary exposure of interest was three or more doses of COVID-19 vaccines. The primary outcome of interest was COVID-19-related death. VE and the number needed to vaccinate (NNV) to prevent one death were estimated in a propensity score-matched cohort, with adjustments for confounders. Among 3,730,007 reported pediatric cases, 5472 (0.1%) died, 99% of whom did not receive a booster dose. During the pandemic, the VE against death was higher in children with comorbidities (92.7% [95% CI, 63.5\u201399.0]; NNV = 23 [19\u201330]) than in those without (68.2% [25.7\u201386.4]; NNV = 2000 [1111\u20139774]). During the endemic period, the VE against death remained high and was comparable between groups: 89.4% (29.8\u201398.7) and 75.8% (36.4\u201395.7) for children with and without comorbidities, respectively. Nevertheless, NNV levels were significantly lower in children with comorbidities, reflecting an increased risk at baseline. Although booster doses continue to offer substantial protection against fatal COVID-19 outcomes, the magnitude of this benefit is directly correlated with the baseline risk. Consequently, these findings support the implementation of risk-based prioritization strategies in public health decision-making for children.<\/jats:p>","DOI":"10.3390\/microorganisms14040883","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:24:58Z","timestamp":1776176698000},"page":"883","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of COVID-19 Vaccine Boosters in Children Across Pandemic and Endemic Periods"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-7164","authenticated-orcid":false,"given":"Eduardo A.","family":"Oliveira","sequence":"first","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-6769","authenticated-orcid":false,"given":"Maria Christina L.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-2802","authenticated-orcid":false,"given":"Herc\u00edlio","family":"Martelli-J\u00fanior","sequence":"additional","affiliation":[{"name":"Health Science\/Primary Care Postgraduate Program, State University of Montes Claros (Unimontes), Montes Claros 39401-089, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-1179","authenticated-orcid":false,"given":"Fabr\u00edcio Emanuel S.","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Health Science\/Primary Care Postgraduate Program, State University of Montes Claros (Unimontes), Montes Claros 39401-089, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3979-7497","authenticated-orcid":false,"given":"Daniella R. B.","family":"Martelli","sequence":"additional","affiliation":[{"name":"Health Science\/Primary Care Postgraduate Program, State University of Montes Claros (Unimontes), Montes Claros 39401-089, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1138-2912","authenticated-orcid":false,"given":"Rayner","family":"Santos","sequence":"additional","affiliation":[{"name":"Department of Statistics, University Federal of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8512-9000","authenticated-orcid":false,"given":"Robert H.","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Nephrology, University of California, San Diego, CA 92110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-3882","authenticated-orcid":false,"given":"Ana Cristina","family":"Sim\u00f5es e Silva","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-4377","authenticated-orcid":false,"given":"Lilian M.","family":"Diniz","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6559-3300","authenticated-orcid":false,"given":"Cristiane S.","family":"Dias","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5314-6355","authenticated-orcid":false,"given":"Lays R. C.","family":"Foligno","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1918-3839","authenticated-orcid":false,"given":"Rafaela R.","family":"Herrerias","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2647-4335","authenticated-orcid":false,"given":"Ana Livia O.","family":"Andrade","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2350-4935","authenticated-orcid":false,"given":"Isabella O.","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Health Sciences Postgraduate Program, Department of Pediatrics, School of Medicine, University Federal of Minas Gerais (UFMG), Belo Horizonte 30130-100, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8705-4674","authenticated-orcid":false,"given":"Enrico A.","family":"Colosimo","sequence":"additional","affiliation":[{"name":"Department of Statistics, University Federal of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Berra, T.Z., Alves, Y.M., Popolin, M.A.P., da Costa, F.B.P., Tavares, R.B.V., Tartaro, A.F., Moura, H.S.D., Ferezin, L.P., de Campos, M.C.T., and Ribeiro, N.M. (2024). The COVID-19 pandemic in Brazil: Space-time approach of cases, deaths, and vaccination coverage (February 2020\u2013April 2024). BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09598-1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s43856-024-00633-5","article-title":"Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza","volume":"4","author":"Bartha","year":"2024","journal-title":"Commun. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100664","DOI":"10.1016\/j.lanepe.2023.100664","article-title":"From emergency response to long-term management: The many faces of the endemic state of COVID-19","volume":"30","author":"Contreras","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1473-3099(25)00349-4","article-title":"Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022\u201323): A prospective, multicentre, longitudinal, immunoepidemiological surveillance study","volume":"26","author":"Park","year":"2026","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/infdis\/jiae295","article-title":"Outcomes of SARS-CoV-2 and seasonal viruses among 2 million adults hospitalized for severe acute respiratory infection during the COVID-19 pandemic in Brazil","volume":"230","author":"Diniz","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.abe6522","article-title":"Immunological characteristics govern the transition of COVID-19 to endemicity","volume":"371","author":"Lavine","year":"2021","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-021-03792-w","article-title":"After the pandemic: Perspectives on the future trajectory of COVID-19","volume":"596","author":"Telenti","year":"2021","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Plans-Rubio, P. (2024). What COVID-19 Vaccination Strategy Should Be Implemented and Which Vaccines Should Be Used in the Post-Pandemic Era?. Vaccines, 12.","DOI":"10.3390\/vaccines12101180"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMsb2506929","article-title":"An Evidence-Based Approach to COVID-19 Vaccination","volume":"392","author":"Prasad","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Committee on Infectious Diseases, O\u2019lEary, S.T., Campbell, J.D., Ardura, M.I., Bryant, K.A., DeBiasi, R.L., Espinosa, C., Frenck, R.W., Healy, C.M., and Herold, B.C. (2025). Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents: Policy Statement. Pediatrics, 156, e2025073924.","DOI":"10.1542\/peds.2025-073924"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2025072788","DOI":"10.1542\/peds.2025-072788","article-title":"Hospitalization for COVID-19 and Risk Factors for Severe Disease Among Children: 2022\u20132024","volume":"156","author":"Free","year":"2025","journal-title":"Pediatrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1038\/s41467-024-47745-z","article-title":"Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England","volume":"15","author":"Copland","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e2022057313","DOI":"10.1542\/peds.2022-057313","article-title":"Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years","volume":"150","author":"Hause","year":"2022","journal-title":"Pediatrics"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S2352-4642(23)00078-0","article-title":"Safety and effectiveness of vaccines against COVID-19 in children aged 5\u201311 years: A systematic review and meta-analysis","volume":"7","author":"Piechotta","year":"2023","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2449944","DOI":"10.1001\/jamanetworkopen.2024.49944","article-title":"BNT162b2 XBB Vaccine for COVID-19 Among Children 5\u201317 Years of Age","volume":"7","author":"Tartof","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Weber, D.J., Zimmerman, K.O., Tartof, S.Y., McLaughlin, J.M., and Pather, S. (2024). Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review. Vaccines, 12.","DOI":"10.3390\/vaccines12090989"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"102962","DOI":"10.1016\/j.eclinm.2024.102962","article-title":"Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents","volume":"79","author":"Wu","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2459672","DOI":"10.1001\/jamanetworkopen.2024.59672","article-title":"COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years","volume":"8","author":"Yousaf","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Coelho, L.G., Diniz, L.M., Galante, S.C., Dias, C.S., Oliveira, M.C.L., Colosimo, E.A., Simoes, E.S.A.C., Duelis, F.N., Bernardes, M.E.T., and Martelli, D.R. (2026). Effectiveness of COVID-19 Vaccines Against Hospitalization and Severe Disease in Children with Diabetes Mellitus During Pandemic and Post-Pandemic Eras. Microorganisms, 14.","DOI":"10.3390\/microorganisms14020501"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Oliveira, M.C.L., Martelli, D.R., Simoes, E.S.A.C., Dias, C.S., Diniz, L.M., Colosimo, E.A., Pinhati, C.C., Galante, S.C., Duelis, F.N., and Carvalho, L.E. (2025). COVID-19 Vaccine Effectiveness and Risk Factors of Booster Failure in 480,000 Patients with Diabetes Mellitus: A Population-Based Cohort Study. Microorganisms, 13.","DOI":"10.3390\/microorganisms13050979"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1016\/S2214-109X(20)30285-0","article-title":"Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: A cross-sectional observational study","volume":"8","author":"Baqui","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S2352-4642(21)00134-6","article-title":"Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: An analysis of a nationwide database","volume":"5","author":"Oliveira","year":"2021","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_24","first-page":"597","article-title":"Propensity Score: An Alternative Method of Analyzing Treatment Effects","volume":"113","author":"Kuss","year":"2016","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.3399\/bjgp17X692153","article-title":"Comparison between treatment effects in a randomised controlled trial and an observational study using propensity scores in primary care","volume":"67","author":"Stuart","year":"2017","journal-title":"Br. J. Gen. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: A review and a look forward","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2202\/1557-4679.1285","article-title":"A tutorial on methods to estimating clinically and policy-meaningful measures of treatment effects in prospective observational studies: A review","volume":"7","author":"Austin","year":"2011","journal-title":"Int. J. Biostat."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa2203315","article-title":"Evaluation of mRNA-1273 COVID-19 Vaccine in Children 6 to 11 Years of Age","volume":"386","author":"Creech","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age","volume":"386","author":"Walter","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, Immunogenicity, and Efficacy of the BNT162b2 COVID-19 Vaccine in Adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e2022057634","DOI":"10.1542\/peds.2022-057634","article-title":"Vaccine Effectiveness of BNT162b2 Against Delta and Omicron Variants in Adolescents","volume":"150","author":"Buchan","year":"2022","journal-title":"Pediatrics"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1001\/jama.2022.2068","article-title":"Association of Prior BNT162b2 COVID-19 Vaccination with Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance","volume":"327","author":"Britton","year":"2022","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1038\/s41467-022-32524-5","article-title":"Vaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period","volume":"13","author":"Florentino","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S1473-3099(22)00451-0","article-title":"Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: A test-negative case-control study","volume":"22","author":"Florentino","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpeds.2022.09.039","article-title":"Vaccine Effectiveness against SARS-CoV-2 Variants in Adolescents from 15 to 90 Days after Second Dose: A Population-Based Test-Negative Case-Control Study","volume":"253","author":"Oliveira","year":"2023","journal-title":"J. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s12519-023-00699-6","article-title":"Effectiveness of BNT162b2 and CoronaVac vaccines against omicron in children aged 5 to 11 years","volume":"19","author":"Oliveira","year":"2023","journal-title":"World J. Pediatr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2666-5247(21)00069-0","article-title":"COVID-19 vaccine efficacy and effectiveness-the elephant (not) in the room","volume":"2","author":"Olliaro","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.vaccine.2014.12.033","article-title":"How and why researchers use the number needed to vaccinate to inform decision making\u2014A systematic review","volume":"33","author":"Hashim","year":"2015","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/bmjebm-2021-111789","article-title":"Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines","volume":"27","author":"Fassler","year":"2022","journal-title":"BMJ Evid. Based Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"n2034","DOI":"10.1136\/bmj.n2034","article-title":"Real world effectiveness of COVID-19 vaccines","volume":"374","author":"Hungerford","year":"2021","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"114267","DOI":"10.1016\/j.jpeds.2024.114267","article-title":"A Population-Based Epidemiologic Study of Symptomatic SARS-CoV-2 Infections and Fatalities in Brazilian Children over 3 Years","volume":"276","author":"Oliveira","year":"2024","journal-title":"J. Pediatr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Agampodi, S., Tadesse, B.T., Sahastrabuddhe, S., Excler, J.L., and Kim, J.H. (2024). Biases in COVID-19 vaccine effectiveness studies using cohort design. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1474045"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1473-3099(22)00409-1","article-title":"Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant","volume":"22","author":"Higdon","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"ref_47","first-page":"100396","article-title":"Modeling the impact of child vaccination (5\u201311 y) on overall COVID-19 related hospitalizations and mortality in a context of omicron variant predominance and different vaccination coverage paces in Brazil","volume":"17","author":"Muller","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lima, T.M., Palamim, C.V.C., Melani, V.F., Mendes, M.F., Pereira, L.R., and Marson, F.A.L. (2022). COVID-19 Underreporting in Brazil among Patients with Severe Acute Respiratory Syndrome during the Pandemic: An Ecological Study. Diagnostics, 12.","DOI":"10.3390\/diagnostics12061505"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ulrich, E.H., So, G., Zappitelli, M., and Chanchlani, R. (2021). A Review on the Application and Limitations of Administrative Health Care Data for the Study of Acute Kidney Injury Epidemiology and Outcomes in Children. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.742888"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jech-2013-202744","article-title":"Use of administrative medical databases in population-based research","volume":"68","author":"Friger","year":"2014","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s41591-024-02962-3","article-title":"Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children","volume":"30","author":"Zhong","year":"2024","journal-title":"Nat. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1038\/s41467-024-54404-w","article-title":"Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection","volume":"15","author":"Wiegand","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pcl.2022.12.001","article-title":"Coronavirus Disease-2019 Vaccine Hesitancy","volume":"70","author":"Hammershaimb","year":"2023","journal-title":"Pediatr. Clin. N. Am."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/883\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:35:53Z","timestamp":1776177353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["microorganisms14040883"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14040883","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}